Cytomics and drug development
Open Access
- 23 February 2007
- journal article
- Published by Wiley in Cytometry Part A
- Vol. 71A (6) , 349-351
- https://doi.org/10.1002/cyto.a.20393
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Evaluation of CDK Inhibitor SelectivityPublished by Taylor & Francis ,2006
- The 'not invented here' mythNature Reviews Drug Discovery, 2006
- Advanced microscopy solutions for monitoring the kinetics and dynamics of drug?DNA targeting in living cellsAdvanced Drug Delivery Reviews, 2005
- Boosting accuracy of automated classification of fluorescence microscope images for location proteomicsBMC Bioinformatics, 2004
- A mathematical model for the in vitro kinetics of the anti-cancer agent topotecanMathematical Biosciences, 2004
- Microtubule Stress Modifies Intra-Nuclear Location of Msh2 in Mouse Embryonic FibroblastsCell Cycle, 2004
- Signal transduction inhibitors—a work in progressNature Biotechnology, 2004
- Single cell tracking reveals that Msh2 is a key component of an early-acting DNA damage-activated G2 checkpointOncogene, 2003
- Tracking the cell cycle origins for escape from topotecan action by breast cancer cellsBritish Journal of Cancer, 2003